reviewJournal of Molecular MedicineMar 22, 2011HYBRID OA

AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan

Kuopio University Hospital · University of Eastern Finland

PubMed
Indexed incrossrefpubmed

Abstract

Adenosine monophosphate-activated protein kinase (AMPK) is a crucial regulator of energy metabolic homeostasis and thus a major survival factor in a variety of metabolic stresses and also in the aging process. Metabolic syndrome is associated with a low-grade, chronic inflammation, primarily in adipose tissue. A low-level of inflammation is also present in the aging process. There are emerging results indicating that AMPK signaling can inhibit the inflammatory responses induced by the nuclear factor-κB (NF-κB) system. The NF-κB subunits are not direct phosphorylation targets of AMPK, but the inhibition of NF-κB signaling is mediated by several downstream targets of AMPK, e.g., SIRT1, PGC-1α, p53, and Forkhead…

No related works found for this paper.

Funding